Business · 10/05/2019Updated: 10/17/2026 · 1 min read

FDA Announces Final Guidance to Reduce Risk of Babesiosis in Blood Transfusions

The Food and Drug Administration has released a final guidance document outlining recommendations to minimize the risk of babesiosis transmission through blood transfusions, a serious transfusion-transmitted infection (RTTI) identified by the FDA.